Mahdi Kamoun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mahdi Kamoun has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
Mohamed Abid
Endocrinology Department, Hedi Chaker Hospital, 3029 Sfax, Tunisia
14 shared publicationsNadia Charfi
Endocrinology Department, Hedi Chaker Hospital, 3029 Sfax, Tunisia
12 shared publicationsFatma Mnif
Endocrinology Department, Hedi Chaker Hospital, 3029 Sfax, Tunisia
10 shared publicationsNabila Rekik
Endocrinology Department, Hedi Chaker Hospital, 3029 Sfax, Tunisia
10 shared publicationsBasma Ben Naceur
Endocrinology Department, Hedi Chaker Hospital, 3029 Sfax, Tunisia
8 shared publicationsMouna Feki Mnif
Endocrinology Department, Hedi Chaker Hospital, 3029 Sfax, Tunisia
8 shared publications
Latest Publications
- Open Access
- 30 June 2014
- Published by Springer Nature in Middle East Fertility Society Journal
- Vol. 19 (2) , 89-95
Fertility outcome in male and female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
- 30 June 2014
- Published by Springer Nature in Middle East Fertility Society Journal
- Vol. 19 (2) , 89-95
Open AccessFertility outcome in male and female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
- Open Access
- 1 January 2014
- Published by Pan African Medical Journal in Pan African Medical Journal
- Vol. 17, 57
Prévalence et facteurs de risque du surpoids et de l’obésité dans une population d’enfants scolarisés en milieu urbain à Sfax, Tunisie
INTRODUCTION: L'objectif de ce travail etait d'etudier la pr
- 1 January 2014
- Published by Pan African Medical Journal in Pan African Medical Journal
- Vol. 17, 57
Open AccessPrévalence et facteurs de risque du surpoids et de l’obésité dans une population d’enfants scolarisés en milieu urbain à Sfax, Tunisie
INTRODUCTION: L'objectif de ce travail etait d'etudier la pr
- 1 January 2014
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 347 (1) , 64-73
Adrenal Diseases During Pregnancy: Pathophysiology, Diagnosis and Management Strategies
- 1 January 2014
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 347 (1) , 64-73
Adrenal Diseases During Pregnancy: Pathophysiology, Diagnosis and Management Strategies
- 20 November 2013
- Published by Bioscientifica in European Thyroid Journal
- Vol. 3 (1) , 60-64
Coexistence of Thyroid-Stimulating Hormone-Secreting Pituitary Adenoma and Graves' Hyperthyroidism
Background: Coexistence of thyroid-stimulating hormone (TSH)-secreting pituitary adenoma (TSHoma) with Graves' disease has been rarely reported. We describe a female patient displaying TSHoma with Graves' disease and who presented initially with inappropriate TSH values. Case Report: A 36-year-old woman presented with signs of thyrotoxicosis, small and vascular goiter and mild bilateral exophthalmos. Thyroid function tests showed hyperthyroxinemia and normal TSH values despite the use of different assays. Heterophile antibody testing result was negative. The patient underwent total right lobectomy with partial left lobectomy after 18 months of carbimazole treatment. Histology confirmed Graves' disease. Symptoms of thyrotoxicosis recurred 2 months later. Thyroid function tests showed hyperthyroxinemia and elevated TSH values. Investigations were consistent with a 10-mm TSHoma. The patient underwent a trans-sphenoidal tumor resection following preoperative lanreotide preparation. Histological examination and immunocytochemistry concluded to a pure TSH-producing tumor. There was no evidence of tumor recurrence after 18 years of follow-up. Conclusion: Association of TSHoma with Graves' disease should be carefully taken into account, especially when TSH values are not compatible with either the clinical history or other thyroid functions tests.
- 20 November 2013
- Published by Bioscientifica in European Thyroid Journal
- Vol. 3 (1) , 60-64
Coexistence of Thyroid-Stimulating Hormone-Secreting Pituitary Adenoma and Graves' Hyperthyroidism
Background: Coexistence of thyroid-stimulating hormone (TSH)-secreting pituitary adenoma (TSHoma) with Graves' disease has been rarely reported. We describe a female patient displaying TSHoma with Graves' disease and who presented initially with inappropriate TSH values. Case Report: A 36-year-old woman presented with signs of thyrotoxicosis, small and vascular goiter and mild bilateral exophthalmos. Thyroid function tests showed hyperthyroxinemia and normal TSH values despite the use of different assays. Heterophile antibody testing result was negative. The patient underwent total right lobectomy with partial left lobectomy after 18 months of carbimazole treatment. Histology confirmed Graves' disease. Symptoms of thyrotoxicosis recurred 2 months later. Thyroid function tests showed hyperthyroxinemia and elevated TSH values. Investigations were consistent with a 10-mm TSHoma. The patient underwent a trans-sphenoidal tumor resection following preoperative lanreotide preparation. Histological examination and immunocytochemistry concluded to a pure TSH-producing tumor. There was no evidence of tumor recurrence after 18 years of follow-up. Conclusion: Association of TSHoma with Graves' disease should be carefully taken into account, especially when TSH values are not compatible with either the clinical history or other thyroid functions tests.
- Open Access
- 1 November 2013
- Published by Wolters Kluwer Health in Indian Journal of Endocrinology and Metabolism
- Vol. 17 (6) , 1104-1107
Hyperthyroidism: A rare cause of pulmonary embolism: Report of two cases
Several disorders of coagulation and fibrinolysis have been widely reported in patients with hyperthyroidism. Most reports have focused on only the venous thromboembolism risk, and few of them have studied specifically the association between hyperthyroidism and pulmonary embolism (PE). We report two cases of Graves’ disease complicated by PE. The first patient is a 32 year-old man, and the second patient is a 23-year-old female. PE was suspected on the basis of pulmonary hypertension in patient one, and clinical presentation in the other patient. The first patient had also right heart failure. PE was confirmed in both patients by a lung perfusion-ventilation scan test. Thrombophilia screen revealed normal findings in the first patient and an elevation in coagulation factor VIII in the second one. Both patients received heparin, followed by oral anticoagulant therapy. In addition, they were treated with radioactive iodine resulting in partial recovery from hyperthyroidismforpatient oneand clinical euthyroidism for patient two. The former died of acute heart failure secondary to a chest infection, while the later was lost to follow-up. In conclusion, hyperthyroidism is associated with increased risk of venous thromboembolism, including PE. Potential mechanisms involved in this association include endothelial dysfunction, decreased fibrinolytic activity, and increased coagulation factors levels. Thyroid evaluation is recommended in patients with unprovoked venous thromboembolic events. Conversely, the diagnosis of venous thromboembolism should be considered in patients with hyperthyroidism, particularly if additional prothrombotic risk factors are present.
- 1 November 2013
- Published by Wolters Kluwer Health in Indian Journal of Endocrinology and Metabolism
- Vol. 17 (6) , 1104-1107
Open AccessHyperthyroidism: A rare cause of pulmonary embolism: Report of two cases
Several disorders of coagulation and fibrinolysis have been widely reported in patients with hyperthyroidism. Most reports have focused on only the venous thromboembolism risk, and few of them have studied specifically the association between hyperthyroidism and pulmonary embolism (PE). We report two cases of Graves’ disease complicated by PE. The first patient is a 32 year-old man, and the second patient is a 23-year-old female. PE was suspected on the basis of pulmonary hypertension in patient one, and clinical presentation in the other patient. The first patient had also right heart failure. PE was confirmed in both patients by a lung perfusion-ventilation scan test. Thrombophilia screen revealed normal findings in the first patient and an elevation in coagulation factor VIII in the second one. Both patients received heparin, followed by oral anticoagulant therapy. In addition, they were treated with radioactive iodine resulting in partial recovery from hyperthyroidismforpatient oneand clinical euthyroidism for patient two. The former died of acute heart failure secondary to a chest infection, while the later was lost to follow-up. In conclusion, hyperthyroidism is associated with increased risk of venous thromboembolism, including PE. Potential mechanisms involved in this association include endothelial dysfunction, decreased fibrinolytic activity, and increased coagulation factors levels. Thyroid evaluation is recommended in patients with unprovoked venous thromboembolic events. Conversely, the diagnosis of venous thromboembolism should be considered in patients with hyperthyroidism, particularly if additional prothrombotic risk factors are present.
- Open Access
- 1 November 2013
- Published by Wolters Kluwer Health in Indian Journal of Endocrinology and Metabolism
- Vol. 17 (6) , 1040-1045
The effects of an exercise training program on body composition and aerobic capacity parameters in Tunisian obese children
Background: The prevalence of children obesity is rising alarmingly in both developed and developing countries. Developing effective exercise programs is a strategy for decreasing this prevalence and limiting obesity-associated long-term comorbidities. Objectives: To determine whether a 16-week training program; in addition to the school physical education and without dietary intervention; could have beneficial effects on body composition and aerobic capacity of obese children. Materials and Methods: Twenty-eight obese children (16 boys, 12 girls; aged 12-14 years) were enrolled and were divided into either the exercise group (EG, n = 14) or the control group (CG, n = 14). EG participated in a 16-week aerobic exercises (four 60-min sessions per week at 70-85% of HRmax (maximum heart rate)), in addition to the school physical education. Fat-Free Mass (FFM) and Fat Mass (FM) were assessed with bioelectrical impedance equipment. To assess aerobic capacity, maximal metabolic equivalent of task (METmax) and maximal workload (Wmax) were estimated with an electronically braked cycle ergometer (type Ergoline 500 ® ). Results: At baseline, there were no differences between the two groups. After the training program, only the EG showed significant reduction in BMI (body mass index) and waist circumference compared with the baseline values ( P < 0.001). Exercise training significantly decreased FM only in the EG. A significant increase in FFM was seen in both groups; more marked in the EG. There was a significant increase in METmax ( P < 0.05) and Wmax ( P = 0.02) in the EG, and no significant changes in these parameters were seen in the CG. HRmax significantly decreased only in the EG ( P < 0.05). Conclusion: This training program has beneficial effects on body composition and aerobic capacity parameters in obese children. Our intervention has the advantage of providing a sustainable and reproducible school and community approach for the management of children obesity.
- 1 November 2013
- Published by Wolters Kluwer Health in Indian Journal of Endocrinology and Metabolism
- Vol. 17 (6) , 1040-1045
Open AccessThe effects of an exercise training program on body composition and aerobic capacity parameters in Tunisian obese children
Background: The prevalence of children obesity is rising alarmingly in both developed and developing countries. Developing effective exercise programs is a strategy for decreasing this prevalence and limiting obesity-associated long-term comorbidities. Objectives: To determine whether a 16-week training program; in addition to the school physical education and without dietary intervention; could have beneficial effects on body composition and aerobic capacity of obese children. Materials and Methods: Twenty-eight obese children (16 boys, 12 girls; aged 12-14 years) were enrolled and were divided into either the exercise group (EG, n = 14) or the control group (CG, n = 14). EG participated in a 16-week aerobic exercises (four 60-min sessions per week at 70-85% of HRmax (maximum heart rate)), in addition to the school physical education. Fat-Free Mass (FFM) and Fat Mass (FM) were assessed with bioelectrical impedance equipment. To assess aerobic capacity, maximal metabolic equivalent of task (METmax) and maximal workload (Wmax) were estimated with an electronically braked cycle ergometer (type Ergoline 500 ® ). Results: At baseline, there were no differences between the two groups. After the training program, only the EG showed significant reduction in BMI (body mass index) and waist circumference compared with the baseline values ( P < 0.001). Exercise training significantly decreased FM only in the EG. A significant increase in FFM was seen in both groups; more marked in the EG. There was a significant increase in METmax ( P < 0.05) and Wmax ( P = 0.02) in the EG, and no significant changes in these parameters were seen in the CG. HRmax significantly decreased only in the EG ( P < 0.05). Conclusion: This training program has beneficial effects on body composition and aerobic capacity parameters in obese children. Our intervention has the advantage of providing a sustainable and reproducible school and community approach for the management of children obesity.
- Open Access
- 1 September 2013
- Published by Wolters Kluwer Health in Indian Journal of Endocrinology and Metabolism
- Vol. 17 (5) , 790-793
Reproductive outcomes of female patients with congenital adrenal hyperplasia due to 21-hydroxylase defi ciency
Fertility in women with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21-OHD) appears to be reduced, especially in women with the classic salt-wasting type. Several factors have been suggested to contribute to this subfertility such as androgen excess, adrenal progesterone hypersecretion, consequences of genital reconstructive surgery, secondary polycystic ovaries syndrome, and psychosexual factors. In contrast to this subfertility, pregnancies are commonly normal and uneventful. Adequate glucocorticoid therapy and improvement of surgical and psychological management could contribute to optimize fertility in CAH female patients, even among women with the classic variant. This review provides current information regarding the reproductive outcomes of women with CAH due to 21-OHD and the fertility and pregnancy issues in this population.
- 1 September 2013
- Published by Wolters Kluwer Health in Indian Journal of Endocrinology and Metabolism
- Vol. 17 (5) , 790-793
Open AccessReproductive outcomes of female patients with congenital adrenal hyperplasia due to 21-hydroxylase defi ciency
Fertility in women with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21-OHD) appears to be reduced, especially in women with the classic salt-wasting type. Several factors have been suggested to contribute to this subfertility such as androgen excess, adrenal progesterone hypersecretion, consequences of genital reconstructive surgery, secondary polycystic ovaries syndrome, and psychosexual factors. In contrast to this subfertility, pregnancies are commonly normal and uneventful. Adequate glucocorticoid therapy and improvement of surgical and psychological management could contribute to optimize fertility in CAH female patients, even among women with the classic variant. This review provides current information regarding the reproductive outcomes of women with CAH due to 21-OHD and the fertility and pregnancy issues in this population.
- 1 May 2013
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 74 (2) , 157
Hibernoma and type 1 multiple endocrine neoplasia (MEN1)? A metabolic link?
- 1 May 2013
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 74 (2) , 157
Hibernoma and type 1 multiple endocrine neoplasia (MEN1)? A metabolic link?
- Open Access
- 1 May 2013
- Published by Wolters Kluwer Health in Indian Journal of Endocrinology and Metabolism
- Vol. 17 (3) , 505-508
Gonadal dysgenesis and the Mayer-Rokitansky-Kuster-Hauser Syndrome in a girl with a 46, XX karyotype: A case report and review of literature
Mayer-Rokitansky-Kuster-Hauser (MRKH) is a characteristic syndrome in which the Mullerian structures are absent or rudimentary. It is also associated with anomalies of the genitourinary and skeletal systems. Its association with gonadal dysgenesis is extremely rare and appears to be fortuitous, independent of chromosomal anomalies. We report such a case in a 21-year-old girl who presented primary amenorrhea and impuberism. The endocrine study revealed hypergonadotrophic hypogonadism. The karyotype was normal, 46, XX. No chromosome Y was detected at the fluorescence in situ hybridization (FISH) analysis. Internal genitalia could not be identified on the pelvic ultrasound and pelvic magnetic resonance imaging. Laparoscopy disclosed concomitant ovarian dysgenesis and MRKH syndrome. There were no other associated malformations. Hormonal substitution therapy with oral conjugated estrogens was begun. The patient has been under regular follow-up for the last two years and is doing well.
- 1 May 2013
- Published by Wolters Kluwer Health in Indian Journal of Endocrinology and Metabolism
- Vol. 17 (3) , 505-508
Open AccessGonadal dysgenesis and the Mayer-Rokitansky-Kuster-Hauser Syndrome in a girl with a 46, XX karyotype: A case report and review of literature
Mayer-Rokitansky-Kuster-Hauser (MRKH) is a characteristic syndrome in which the Mullerian structures are absent or rudimentary. It is also associated with anomalies of the genitourinary and skeletal systems. Its association with gonadal dysgenesis is extremely rare and appears to be fortuitous, independent of chromosomal anomalies. We report such a case in a 21-year-old girl who presented primary amenorrhea and impuberism. The endocrine study revealed hypergonadotrophic hypogonadism. The karyotype was normal, 46, XX. No chromosome Y was detected at the fluorescence in situ hybridization (FISH) analysis. Internal genitalia could not be identified on the pelvic ultrasound and pelvic magnetic resonance imaging. Laparoscopy disclosed concomitant ovarian dysgenesis and MRKH syndrome. There were no other associated malformations. Hormonal substitution therapy with oral conjugated estrogens was begun. The patient has been under regular follow-up for the last two years and is doing well.
- Open Access
- 1 May 2013
- Published by Wolters Kluwer Health in Indian Journal of Endocrinology and Metabolism
- Vol. 17 (3) , 442-445
Complicated urinary tract infections associated with diabetes mellitus: Pathogenesis, diagnosis and management
Diabetes mellitus has a number of long-term effects on the genitourinary system. These effects predispose to bacterial urinary tract infections (UTIs) in the patient with diabetes mellitus. Complicated UTIs are also common and potentially life-threatening conditions. They include emphysematous pyelonephritis, emphysematous pyelitis/cystitis, xanthogranulomatous pyelonephritis, renal/perirenal abscess, and renal papillary necrosis. Improved outcomes of these entities may be achieved by early diagnosis, knowledge of common predisposing factors, appropriate clinical and radiological assessment, and prompt management. Herein we review complicated UTIs associated with diabetes mellitus in terms of pathogenesis, clinical manifestations, radiological features, and current management options.
- 1 May 2013
- Published by Wolters Kluwer Health in Indian Journal of Endocrinology and Metabolism
- Vol. 17 (3) , 442-445
Open AccessComplicated urinary tract infections associated with diabetes mellitus: Pathogenesis, diagnosis and management
Diabetes mellitus has a number of long-term effects on the genitourinary system. These effects predispose to bacterial urinary tract infections (UTIs) in the patient with diabetes mellitus. Complicated UTIs are also common and potentially life-threatening conditions. They include emphysematous pyelonephritis, emphysematous pyelitis/cystitis, xanthogranulomatous pyelonephritis, renal/perirenal abscess, and renal papillary necrosis. Improved outcomes of these entities may be achieved by early diagnosis, knowledge of common predisposing factors, appropriate clinical and radiological assessment, and prompt management. Herein we review complicated UTIs associated with diabetes mellitus in terms of pathogenesis, clinical manifestations, radiological features, and current management options.